Clinical Trial Update: Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once Daily [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating simplification of HIV antiretroviral therapy to once-daily efavirenz + abacavir + lamivudine; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• EFAVIRENZ (efavirenz)
• Lamivudine (lamivudine)
• abacavir (abacavir)

Snippet

Sponsor: Germans Trias i Pujol Hospital | Conditions: HIV Infections | Phase 3 | Status: COMPLETED